Lumida
/RXST
⌘K
Rxsight Inc

Rxsight Inc

RXST
$5.55USD-0.36%-0.02 today

MARKET CAP

229.8M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $6

52W RANGE

$4
$13

AI Summary

Stalk
Sell NowMedium

RXST remains locked in a Stage 4 decline with a persistent sequence of lower highs and lower lows, trading below the 50 DMA and 200 DMA. The recent bounce above the 9 EMA/21 EMA offers a clean speculative sell entry in line with the dominant downtrend. No primary patterns support a bullish reversal, so execution should capitalize on resumed weakness while respecting resistance zones. A close above key moving averages would invalidate this bearish posture.

  • Proprietary LAL platform uniquely differentiates RxSight in premium IOL market
  • Q1 gross margin rose to 76.1% from 74.8% YoY, reflecting improved product mix
  • Q1 2026 sales declined 18% YoY to $30.9M, signaling demand weakness
Full analysis →
Loading graphs…